Tag: Children’s

Posted on

Heavy metals in PM2.5 and in blood, and children’s respiratory symptoms and asthma from an e-waste recycling area.

Related Articles

Heavy metals in PM2.5 and in blood, and children’s respiratory symptoms and asthma from an e-waste recycling area.

Environ Pollut. 2016 Jan 21;210:346-353

Authors: Zeng X, Xu X, Zheng X, Reponen T, Chen A, Huo X

Abstract
This study was to investigate the levels of heavy metals in PM2.5 and in blood, the prevalence of respiratory symptoms and asthma, and the related factors to them. Lead and cadmium in both PM2.5 and blood were significant higher in Guiyu (exposed area) than Haojiang (reference area) (p < 0.05), however, no significant difference was found for chromium and manganese in PM2.5 and in blood. The prevalence of cough, phlegm, dyspnea, and wheeze of children was higher in Guiyu compared to Haojiang (p < 0.05). No significant difference was found for the prevalence of asthma in children between Guiyu and Haojiang. Living in Guiyu was positively associated with blood lead (B = 0.196, p < 0.001), blood cadmium (B = 0.148, p < 0.05) and cough (OR, 2.37; 95% CI, 1.30-4.32; p < 0.01). Blood lead>5 ?g/dL was significantly associated with asthma (OR, 9.50; 95% CI, 1.16-77.49). Higher blood chromium and blood manganese were associated with more cough and wheeze, respectively. Our data suggest that living in e-waste exposed area may lead to increased levels of heavy metals, and accelerated prevalence of respiratory symptoms and asthma.

PMID: 26803791 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Posted on

Valley Children’s recognized for asthma treatment, maternal-fetal care – Fresno Business Journal

Valley Children's recognized for asthma treatment, maternal-fetal care
Fresno Business Journal
Two national healthcare organizations have recognized Valley Children's Hospital for performing exceptionally well on evidence-based care processes for the treatment of children's asthma and maternal-fetal care. Due to its extraordinary performance in …

View full post on asthma – Google News

Posted on

Asthma management drugs can affect children’s growth, says new study – ChristianToday


ChristianToday

Asthma management drugs can affect children's growth, says new study
ChristianToday
Corticosteroids are popular drugs prescribed in the management of asthma, but a new study finds that certain types may affect growth in very young children. In a research presentation given at the annual European Society for Pediatric Endocrinology …

View full post on asthma – Google News

Posted on

Caregiver treatment satisfaction is improved together with children’s asthma control: Prospective study for budesonide monotherapy in school-aged children with uncontrolled asthma symptoms.

Related Articles

Caregiver treatment satisfaction is improved together with children’s asthma control: Prospective study for budesonide monotherapy in school-aged children with uncontrolled asthma symptoms.

Allergol Int. 2015 Oct;64(4):371-6

Authors: Yoshihara S, Kanno N, Fukuda H, Arisaka O, Arita M, Sekine K, Yamaguchi K, Tsuchida A, Yamada Y, Watanabe T, Shimizu T, Nishikawa K, Nishimuta T

Abstract
BACKGROUND: If asthmatic children cannot obtain sufficient control of their disease, not only do they suffer from asthma symptoms, but the daily life activities of their caregivers are also disrupted. We investigated the effectiveness of an inhaled corticosteroid (ICS) for symptom control in previously ICS-untreated school-aged asthmatic children as well as caregiver treatment satisfaction (CTS).
METHODS: A multicenter, open-label, single-arm study on 12-week ICS (budesonide Turbuhaler(®)) monotherapy was undertaken in subjects aged 5-15 years with bronchial asthma not treated with ICS during the previous 3 months. At 0, 4, 8, and 12 weeks after start of ICS administration, Japanese Pediatric Asthma Control Program (JPAC) scores, and CTS scores were summated and lung function measured. At weeks 0 and 12, questionnaires on caregiver anxiety were also assessed.
RESULTS: Seventy-five patients were enrolled, and 69 assessed. Ninety percent of subjects had been treated with asthma controller medication except ICS before study enrollment. JPAC score and CTS score were improved significantly at weeks 4, 8, and 12 (p < 0.001). With regard to CTS, more than half of caregivers showed a perfect score at weeks 8 and 12. There was a significant correlation between JPAC score and CTS score. Lung function and caregiver anxiety were also improved, and good compliance with treatment was observed during the intervention.
CONCLUSIONS: If treating ICS-untreated school-aged asthmatic children with uncontrolled symptoms, ICS monotherapy can improve CTS along with improving asthma control.

PMID: 26433534 [PubMed – in process]

View full post on pubmed: asthma